APA (7th ed.) Citation

PF, M., KW, E., A, A., K, C., X, Z., H, Z., . . . F, M. (2015). Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. PloS one, 10(9), e0136851. https://doi.org/10.1371/journal.pone.0136851

Chicago Style (17th ed.) Citation

PF, McAuliffe, et al. "Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes." PloS One 10, no. 9 (2015): e0136851. https://doi.org/10.1371/journal.pone.0136851.

MLA (9th ed.) Citation

PF, McAuliffe, et al. "Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes." PloS One, vol. 10, no. 9, 2015, p. e0136851, https://doi.org/10.1371/journal.pone.0136851.